Informations:
Erreur:
ID
13146
Description
Study Using Vaccination With Heat Shock Protein 70 (HSP70) for the Treatment of CML in Chronic Phase; ODM derived from: https://clinicaltrials.gov/show/NCT00027144
Lien
https://clinicaltrials.gov/show/NCT00027144
Mots-clés
Versions (1)
- 19/01/2016 19/01/2016 -
Téléchargé le
19 janvier 2016
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Leukemia,Myeloid, Chronic NCT00027144
Eligibility Leukemia,Myeloid, Chronic NCT00027144
- StudyEvent: Eligibility
Similar models
Eligibility Leukemia,Myeloid, Chronic NCT00027144
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
ecog
Item
ecog performance score(ps) less than 2.
boolean
C1520224 (UMLS CUI [1])
age, informed consent
Item
must be at least 18 years of age and capable of giving informed consent.
boolean
C0001779 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
C0021430 (UMLS CUI [2])
philadelphia chromosome positive cml in chronic phase
Item
must be less than three years from the original diagnosis of philadelphia chromosome positive cml in chronic phase.
boolean
C0023474 (UMLS CUI [1,1])
C0856536 (UMLS CUI [1,2])
C0856536 (UMLS CUI [1,2])
remission
Item
patient is not in cytogenetic remission.
boolean
C0544452 (UMLS CUI [1])
transplant
Item
no anticipation of bone marrow or stem cell transplant for six months unless these therapies are deemed necessary by a treatment physician due to the evolution of the disease;
boolean
C0472699 (UMLS CUI [1])
medication
Item
concurrent treatment with hydroxyurea or gleevec is allowed.past treatment with ifn alpha, ara-c or other cytoxic agents is allowed
boolean
C0013227 (UMLS CUI [1])
comorbidity
Item
must not have any serious illness such that their medical condition might be compromised by participation in the study.
boolean
C0009488 (UMLS CUI [1])
creatinine, bilirubin, transaminases
Item
must have adequate renal function (serum creatinine < 2.0), hepatic function (bilirubin and transaminase less than 2.0 x of the upper normal limit).
boolean
C0201976 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0002594 (UMLS CUI [3])
C1278039 (UMLS CUI [2])
C0002594 (UMLS CUI [3])
immunosuppressive agents
Item
must not be on corticosteroid therapy, or other immunosuppressive medications.
boolean
C0021081 (UMLS CUI [1])
ecog
Item
patients with an ecog performance score greater than or equal to 2.
boolean
C1520224 (UMLS CUI [1])
time of diagnosis
Item
patient is greater than or equal to 3 years out from the original diagnosis.
boolean
C0011900 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
transfusion
Item
significant anemia (hemoglobin < 10 g/dl) and thrombocytopenia (platelet < 20,000/ml) requiring transfusion.
boolean
C0518015 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C1879316 (UMLS CUI [3])
C0032181 (UMLS CUI [2])
C1879316 (UMLS CUI [3])
peripheral blast count
Item
peripheral blast count is over 10%.
boolean
C0523113 (UMLS CUI [1])
pregnancy test
Item
positive urine or blood pregnancy test.
boolean
C0032976 (UMLS CUI [1])
creatinine, bilirubin, transaminases
Item
impaired renal function (serum creatinine > 2.0), hepatic function (bilirubin and transaminase more than 2.0 x of the upper normal limit).
boolean
C0201976 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0002594 (UMLS CUI [3])
C1278039 (UMLS CUI [2])
C0002594 (UMLS CUI [3])
infection
Item
patient with significant active infection requiring hospitalization at the time of enrollment.
boolean
C0009450 (UMLS CUI [1])
follow-up
Item
patient with significant behavioral or psychological problems that prevent adequate follow-up.
boolean
C1522577 (UMLS CUI [1])
concurrent treatment
Item
concurrent treatment with ifn alpha ara-c or other cytotoxic agents (gleevec and hydroxyurea are allowed.
boolean
C0013227 (UMLS CUI [1])